PolyU develops novel antibody targeting fat cell protein, offering new approach to treating metabolism-related liver cancer (IMAGE)
Caption
Identification of FABP4 as an important secretome conferring CSC properties in HCC cells.
Credit
polyu
Usage Restrictions
nil
License
Original content